Page 7 - Olink Explore News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Investegate announcements from Olink Proteomics AB, Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies

At ENDO 2022, Ascendis will share Phase II and III data showing clinical efficacy for its investigational product candidate for hypoparathyroidism. For this and more, see inside.

07.06.2022 - Element Biosciences to provide proof-of-concept findings during panel discussion at the Advances in Genome Biology and Technology (AGBT) general meeting Olink continues its pioneering efforts to enable Explore broadly across genomics ... Seite 1

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) and SeqLL (NASDAQ:SQL – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation. Earnings & Valuation This table compares Olink Holding […]

Analysts forecast that Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) will report $26.52 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Olink Holding AB (publ)’s earnings, with estimates ranging from $26.39 million to $26.65 million. Olink Holding AB (publ) reported sales of $17.69 million in the […]

Wall Street brokerages predict that Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) will announce $26.52 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Olink Holding AB (publ)’s earnings. The highest sales estimate is $26.65 million and the lowest is $26.39 million. Olink Holding AB (publ) […]

Investegate announcements from Olink Proteomics AB, Pharma Foods International and Olink initiate strategic partnership in Japan

Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) and Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends. Insider & Institutional Ownership 47.9% of Nautilus […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday, Zacks.com reports. The brokerage presently has a $13.00 target price on the stock. Zacks Investment Research‘s price target points to a potential upside of 20.48% from the […]